We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-15.78%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$182M
AUM Growth
-$31.3M
Cap. Flow
+$2.88M
Cap. Flow %
1.59%
Top 10 Hldgs %
35.11%
Holding
111
New
11
Increased
18
Reduced
20
Closed
15

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.18M
2
TGT icon
Target
TGT
+$3.34M
3
COST icon
Costco
COST
+$3.32M
4
MDT icon
Medtronic
MDT
+$3.05M
5
AMZN icon
Amazon
AMZN
+$2.84M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.7M
2
EL icon
Estee Lauder
EL
+$2.51M
3
TJX icon
TJX Companies
TJX
+$2.17M
4
COF icon
Capital One
COF
+$1.93M
5
WEC icon
WEC Energy
WEC
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 24.99%
2 Healthcare 13.48%
3 Financials 12.24%
4 Communication Services 9.73%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
51
Cisco
CSCO
$483B
$1.1M 0.6%
+25,700
New +$1.23M
AMAT icon
52
Applied Materials
AMAT
$415B
$1.09M 0.6%
+12,000
New +$1.32M
META icon
53
Meta Platforms (Facebook)
META
$1.52T
$1.07M 0.59%
6,614
-3,725
-36% -$719K
LIN icon
54
Linde
LIN
$227B
$1.04M 0.58%
3,635
HIG icon
55
Hartford Financial Services
HIG
$38.7B
$1.02M 0.56%
15,575
UPS icon
56
United Parcel Service
UPS
$89.1B
$1.02M 0.56%
5,585
+3,100
+125% +$565K
PFE icon
57
Pfizer
PFE
$154B
$990K 0.55%
18,875
CHRW icon
58
C.H. Robinson
CHRW
$17.3B
$934K 0.51%
9,211
-2,760
-23% -$288K
PXD
59
DELISTED
Pioneer Natural Resource Co.
PXD
$856K 0.47%
3,838
BMRN icon
60
BioMarin Pharmaceuticals
BMRN
$13.3B
$773K 0.43%
9,330
EMR icon
61
Emerson Electric
EMR
$88.5B
$761K 0.42%
9,573
ELAN icon
62
Elanco Animal Health
ELAN
$11.1B
$736K 0.41%
37,495
APD icon
63
Air Products & Chemicals
APD
$68.6B
$733K 0.4%
3,050
LNG icon
64
Cheniere Energy
LNG
$54.9B
$729K 0.4%
5,480
+850
+18% +$116K
COP icon
65
ConocoPhillips
COP
$148B
$703K 0.39%
7,823
-1,850
-19% -$191K
VTRS icon
66
Viatris
VTRS
$18.7B
$698K 0.38%
66,675
T icon
67
AT&T
T
$165B
$673K 0.37%
32,125
-10,409
-24% -$208K
SBUX icon
68
Starbucks
SBUX
$119B
$666K 0.37%
8,714
+564
+7% +$43.3K
DE icon
69
Deere & Co
DE
$164B
$665K 0.37%
2,222
PPG icon
70
PPG Industries
PPG
$25.7B
$637K 0.35%
5,570
AVY icon
71
Avery Dennison
AVY
$13.5B
$620K 0.34%
3,831
SNA icon
72
Snap-on
SNA
$21.3B
$618K 0.34%
3,139
-1,411
-31% -$301K
SHEL icon
73
Shell
SHEL
$249B
$607K 0.33%
11,600
PVH icon
74
PVH
PVH
$4.02B
$571K 0.31%
10,039
+4,050
+68% +$280K
VRTX icon
75
Vertex Pharmaceuticals
VRTX
$133B
$562K 0.31%
+1,995
New +$534K

Similar funds

Stoneridge Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Stoneridge Investment Partners held 111 positions worth $182M, down 15% from $213M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stoneridge Investment Partners's Q2 2022 filing shows 11 new, 18 increased, 20 reduced and 15 closed positions. Its largest new stake was Procter & Gamble: 27,782 shares worth $4M. The largest sale was Johnson & Johnson, an estimated $3.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Stoneridge Investment Partners's largest Q2 2022 buy was Procter & Gamble: 27,782 shares worth $4M.
  • Stoneridge Investment Partners added most to Target in Q2 2022, an estimated $3.34M increase.
  • Stoneridge Investment Partners's biggest Q2 2022 reduction was Johnson & Johnson, cutting an estimated $3.7M.
  • Stoneridge Investment Partners fully exited Estee Lauder in Q2 2022, selling an estimated $2.51M.
  • Stoneridge Investment Partners's ten largest holdings make up 35% of its $182M portfolio in Q2 2022.
  • Stoneridge Investment Partners opened 11 new positions and closed 15 in Q2 2022.
  • Stoneridge Investment Partners's portfolio value fell 15% quarter-over-quarter to $182M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2022, filed 1 Aug 2022.